Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan일본 의료 센터에서 BNT162b2 mRNA COVID-19 백신의 효과 및 돌파구에 대한 실제 증거Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Asia Asian BNT162b2 BNT162b2 vaccine breakthrough COVID-19 vaccine delta variant demonstrated Effectiveness Effectiveness. Evidence evidence of hospital hygiene Infection infection control Japan measure mRNA of BNT162b2 Population populations Public hygiene Regulation required retrospective cohort study SARS-CoV-2 Spread Tokyo vaccination Vaccine variant while [DOI] 10.1080/21645515.2021.1984124 PMC 바로가기 [Article Type] Article
Sudden unexpected death in a 17-year-old boy due to unacknowledged adamantinoma-like Ewing sarcomaArticle Published on 2022-12-012022-11-15 Journal: Forensic Science, Medicine, and Pathology [Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료기술, [키워드] Abnormalities Adamantinoma-like Ewing sarcoma addition airway Airway occlusion Analysis analysis anatomical Autopsy Blood Brain break cardiac cause CD99 Cell characterized Chest radiography Complete death diagnosed diagnostic diagnostics died discharged disease Dyspnea EWSR1 excluded expression Forensic Forensic autopsy forensic pathology Germany histopathological hospital immunohistochemistry Invasion Leica Local lung macroscopic male mechanism Microscopy Mild molecular Nasopharyngeal swab neoplasm nucleoli organ oxygen saturation pathology probe SARS-CoV-2 Soft tissue subject sudden Sudden unexpected death. tested Thyroid was performed [DOI] 10.1007/s12024-022-00525-x PMC 바로가기
A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022Article Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory infections acute respiratory syndrome age caused changes in children circulation clinical information collected complete blood count coronavirus disease cough country COVID-19 COVID-19 outbreak COVID-19 pandemic described distribution emerging disease had no highlight hospital Hospitalization Hospitalized impacted Infection Influenza influenza virus influenza viruses Iran lockdown majority male medical condition Nasopharyngeal swab notable outbreak Outbreak. pandemic parameter pathogen Patient patients performed polymerase chain Precaution proportion Real-time PCR reported respiratory respiratory syncytial virus respiratory virus Result risk factor RSV SARS-CoV-2 subject tested threat Transmission viral genome virus virus [DOI] 10.1002/jmv.28065 PMC 바로가기
Detection of SARS-CoV-2 in the indoor air of intensive care unit (ICU) for severe COVID-19 patients and its surroundings: considering the role of environmental conditionsArticle Published on 2022-12-012023-07-06 Journal: Environmental science and pollution research inter [Category] COVID19(2023년), [키워드] Airborne transmission hospital ICU Particulate matter SARS-CoV-2. [DOI] 10.1007/s11356-021-16010-x PMC 바로가기
COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patientsArticle Published on 2022-12-012022-11-15 Journal: Annals of Medicine [Category] COVID19(2023년), SARS, 진단, 치료제, [키워드] addition affecting alleviate antiviral medication antiviral medicine approved Baricitinib Care caused Clinical practice clinical recommendations Community courses COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment COVID-19 treatments Critical deaths develop disease disorder drug Dyspnea effective effective drugs European European Medicines Agency European Union Evidence guidelines. Health healthcare hospital Hospitalization Hospitalized hospitalized patient hypoxia Intervention involved life-threatening lung involvement management Mild moderate molnupiravir monoclonal antibodies monoclonal antibody Most patient Multiorgan dysfunction New outcome public health recommendation Remdesivir Respiratory failure rheumatoid arthritis SARS-CoV-2 Septic shock severe symptom Symptom the disease the patient therapy Thromboembolism Tocilizumab treat Treatment treatment strategy union vaccination [DOI] 10.1080/07853890.2022.2133162 PMC 바로가기
Skin capillary alterations in patients with acute SarsCoV2 infectionArticle Published on 2022-12-012022-11-16 Journal: Journal of hypertension [Category] COVID19(2023년), SARS, 치료기술, [키워드] A significant reduction acute infection acute phase addition alteration Angiogenesis Autopsy blood chemistry C-reactive protein capillary complications correlation COVID-19 demonstrated discharge endothelial damage Endothelial dysfunction Endothelitis evaluated events Evidence explain hospital impairment incidence increase in Infection Inflammation Inflammatory marker inverse correlation Ischemia lymphocyte material oedema organ parameter Patient patients procoagulant promote repeated resulting skin the disease thrombosis tissue vascular effect vasoconstriction viral infection with COVID-19 [DOI] 10.1097/HJH.0000000000003271 PMC 바로가기
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkersArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 바이오마커, 변종, 진단, [키워드] AstraZeneca Biomarker booster case-control study caused Chronic diseases Clinical severity conducted country COVID-19 COVID-19 confirmed patient COVID-19 patient COVID-19 vaccination COVID-19 vaccine CRP level Delta delta variant Delta wave dose doses effective Effectiveness Efficacy expressed females Health homologous homologous vaccination. hospital Hospitalization Hospitalized individual infected with SARS-CoV-2 Iraq Lower males molecular no significant difference no significant effect omicron Omicron variant pandemic Patient patients Pfizer Population Prevent recommendation recorded risk SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 variant severity significantly Symptom the disease the vaccine transmissibility of SARS-CoV-2 vaccination Vaccine variant variants of concern virus VOCs was done WBC [DOI] 10.1002/jmv.28098 PMC 바로가기
Ultrasound assessment of SARS-CoV-2 pneumonia: a literature review for the primary care physicianReview Published on 2022-12-012023-07-08 Journal: Annals of Medicine [Category] COVID19(2023년), [키워드] COVID-19 healthcare hospital novel coronavirus disease primary care SARS-CoV-2 ultrasound. [DOI] 10.1080/07853890.2022.2067896 PMC 바로가기 [Article Type] Review
The role of kidney injury biomarkers in COVID-19COVID-19에서 신장 손상 바이오마커의 역할Review Published on 2022-12-012022-09-11 Journal: Renal failure [Category] 바이오마커, [키워드] Acute kidney injury AKI Biomarker biomarker. Biomarkers clinical settings complex coronavirus coronavirus disease COVID-19 death demonstrated Diagnosis disease Disease progression early diagnosis global pandemic high mortality rate hospital IGFBP7 IL-18 IMPROVE independent risk factor Intervention kidney Kidney injury molecular molecular mechanism molecular mechanisms outbreak outcomes Patient patients with COVID-19 Research Sepsis suPAR unique [DOI] 10.1080/0886022X.2022.2107544 PMC 바로가기 [Article Type] Review
Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trialsCOVID-19 환자의 결과에 대한 콜히친의 영향: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-12-012022-09-11 Journal: Annals of Medicine [Category] 임상, [키워드] 95% CI addition adverse event adverse events Clinical efficacy clinical outcomes ClinicalTrials Cochrane Library Colchicine control group COVID-19 database diarrhoea Effect higher risk hospital Hospital stay improve clinical outcome mean difference mechanical ventilation Meta-analysis Mortality no significant difference non-invasive ventilation non-invasive ventilation. not reduce Odds ratio outcome OVID Patient patients with COVID-19 Placebo placebos randomised controlled trial RCT RCTs receiving risk SARS-CoV-2 searched significant difference significantly higher standard treatment study group Support systematic review the study group Treatment Web of Science [DOI] 10.1080/07853890.2022.2096919 PMC 바로가기 [Article Type] Meta-Analysis